Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

Simon N Rogers

doi:10.1016/j.jebdp.2010.06.005

Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

Simon N Rogers

Research output: Contribution to journal › Article (journal) › peer-review

Abstract

Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

Original language	English
Pages (from-to)	147-149
Journal	Journal of Evidence-Based Dental Practice
Volume	10
Issue number	3
DOIs	https://doi.org/10.1016/j.jebdp.2010.06.005
Publication status	Published - Mar 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jebdp.2010.06.005

Fingerprint

Dive into the research topics of 'Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible'. Together they form a unique fingerprint.

Cite this

@article{86ae7fad53ed47f19d16a3fc163b61cb,

title = "Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible",

abstract = "Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence",

author = "Rogers, {Simon N}",

year = "2010",

month = mar,

doi = "10.1016/j.jebdp.2010.06.005",

language = "English",

volume = "10",

pages = "147--149",

journal = "Journal of Evidence-Based Dental Practice",

issn = "1532-3382",

publisher = "Elsevier",

number = "3",

}

Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible. / Rogers, Simon N.
In: Journal of Evidence-Based Dental Practice, Vol. 10, No. 3, 03.2010, p. 147-149.

Research output: Contribution to journal › Article (journal) › peer-review

TY - JOUR

T1 - Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

AU - Rogers, Simon N

PY - 2010/3

Y1 - 2010/3

N2 - Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

AB - Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

U2 - 10.1016/j.jebdp.2010.06.005

DO - 10.1016/j.jebdp.2010.06.005

M3 - Article (journal)

SN - 1532-3382

VL - 10

SP - 147

EP - 149

JO - Journal of Evidence-Based Dental Practice

JF - Journal of Evidence-Based Dental Practice

IS - 3

ER -